Mebeverine Hydrochloride Aspire Pharma (Malta)

Mebeverine Hydrochloride, the active ingredient in Mebeverine Hydrochloride Aspire Pharma, is an antispasmodic presented as an oral dosage form for oral use. It relaxes smooth muscle in the gastrointestinal tract and is employed to relieve symptoms of irritable bowel syndrome, functional bowel disorders, and intestinal colic.

GNH USA supplies Mebeverine Hydrochloride Aspire Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Mebeverine Hydrochloride acts on gastrointestinal smooth muscle to alleviate spasm in several functional bowel conditions.

- Irritable bowel syndrome: reduces abdominal pain and cramping associated with IBS. - Functional bowel disorders: improves bowel habit regularity and lessens discomfort. - Intestinal colic: eases acute colicky episodes by relaxing intestinal muscle spasms.

Mebeverine Hydrochloride may be associated with several adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild stomach upset. - Dry mouth: reduced salivation. - Headache: transient cranial discomfort. - Dizziness: light‑headed sensation. - Abdominal pain: mild discomfort in the gut. - Fatigue: feeling of tiredness.

Serious or Rare Side Effects: - Allergic skin reaction: rash, itching, or hives. - Hepatotoxicity: signs of liver injury such as jaundice. - Severe hypersensitivity: anaphylactic reactions requiring emergency care. - Cardiac arrhythmia: irregular heartbeat (very rare).

Before prescribing Mebeverine Hydrochloride, clinicians should consider several precautionary measures to ensure patient safety.

- Assess renal function: adjust use in patients with severe renal impairment. - Monitor hepatic function: watch for signs of liver toxicity during therapy. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Use cautiously in the elderly: increased susceptibility to dizziness and falls. - Review concomitant medications: consider potential drug interactions. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mebeverine Hydrochloride can interact with other medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: may increase mebeverine plasma levels, raising risk of side effects. - Anticholinergic agents: can counteract the smooth‑muscle relaxing effect.

Moderate Interactions (Monitor Closely): - Tricyclic antidepressants: may enhance anticholinergic burden. - Other antispasmodics: additive muscle‑relaxant effects could cause excessive GI slowing. - Antihistamines: potential for increased sedation or dry mouth. - Beta‑blockers: may alter cardiovascular response in susceptible patients.